N.J. CONTRASTE financials
A multi-period view of the public annual-account figures reported for N.J. CONTRASTE, with comparable measures and links to available source documents.
Company overviewRegistry number
0453503209
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for N.J. CONTRASTE
2025 versus 2024
- Operating line
- €7,529
- Total assets
- €12,892
- Equity
- -€13,214
-31.5%
-1.6%
+35.4%
Equity ratio -102.5%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €7,529 | - | €12,892 | -€13,214 | - |
| 202431 Dec 2024 | €10,991 | - | €13,095 | -€20,460 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.